Rogaine

Developed to support hair regrowth to address hair thinning.

Strengths: 5 · 10%

Medicine details

Alternative names

Regaine

Therapeutic class

Hair Growth Stimulant

Pharmacological class

Vasodilator

Contraindications

hypersensitivity to minoxidil; pheochromocytoma; damaged or inflamed scalp

Minor side effects

erythema; pruritus; dermatitis; hypertrichosis

Moderate side effects

scalp dryness; local irritation

Dosage forms

Cutaneous solution; Cutaneous foam

Administration route

Cutaneous use

Patient summary

Developed to support hair regrowth to address hair thinning.

Prescription status

P

Manufacturer

Johnson & Johnson

Onset Time

2–4 months

Duration

continuous use required

Storage instructions

Store at room temperature; keep container tightly closed.

Age restrictions

Not for use by individuals under 18 years.

Precautions and warnings

avoid contact with eyes; discontinue if systemic effects occur; avoid exposure to open flame due to flammability of formulation

Serious side effects

tachycardia — requires immediate medical attention; hypotension — requires immediate medical attention

Mechanism of action

Induces vasodilation in scalp vessels and prolongs the anagen (growth) phase of hair follicles to improve thickness and hair density.

Pregnancy and breastfeeding

Pregnancy: Generally contraindicated. Breastfeeding: Consult a physician before use.

Rogaine

Developed to support hair regrowth to address hair thinning.

Editorial Notes

  • Active ingredient(s): Minoxidil
  • Listed indication(s): Androgenetic Alopecia